Mark Tullis
Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.
Aumni, a Salt Lake City-based investment analytics company, wants to become the industry standard analytics platform for venture capital. Its AI monitors the economic position and legal rights of every investment across multiple funds. The company was founded in 2018 and raised a seed round of just over $2
by Mark Tullis
Aumni, a Salt Lake City-based investment analytics company, wants to become the industry standard analytics platform for venture capital. Its AI monitors the economic position and legal rights of every investment across multiple funds. The company was founded in 2018 and raised a seed round of just over $2
by Mark Tullis
After 20 years of hard work Utah robotics company, Sarcos, is an overnight success. On the heels of closing a significant financing led by Rotor Capital, many are learning for the first time about the technology powerhouse that Sarcos Robotics has become. The $40 million Series C financing will help
by Mark Tullis
After 20 years of hard work Utah robotics company, Sarcos, is an overnight success. On the heels of closing a significant financing led by Rotor Capital, many are learning for the first time about the technology powerhouse that Sarcos Robotics has become. The $40 million Series C financing will help
by Mark Tullis
Before 2020, self-checkout was a convenience, but in 2020 it's a critical safety measure. Salt Lake City-based Skip is taking that to a new level in convenience store shopping with their novel cloud platform. CEO Chase Thomason describes it as a “Square for retailers”. The pandemic
by Mark Tullis
Before 2020, self-checkout was a convenience, but in 2020 it's a critical safety measure. Salt Lake City-based Skip is taking that to a new level in convenience store shopping with their novel cloud platform. CEO Chase Thomason describes it as a “Square for retailers”. The pandemic
by Mark Tullis
Clene Nanomedicine, Inc., a Salt Lake City-based clinical-stage biopharmaceutical company, announced August 26, 2020 that it has raised $42.5 million in Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment fund. Participants in the round include existing investors, most connected with
by Mark Tullis
Clene Nanomedicine, Inc., a Salt Lake City-based clinical-stage biopharmaceutical company, announced August 26, 2020 that it has raised $42.5 million in Series D financing. The round was led by SymBiosis II, LLC, a biotech-focused investment fund. Participants in the round include existing investors, most connected with
by Mark Tullis